Medical devices, healthcare technology and the business of care
510(k) clearance · K262975

Arthrex Beaming System

ARTHREX, INC. · Decision date Sep 25, 2026

MEDTECHLEDGER EXPLANATIONK262975

What did the FDA decide?

Arthrex, Inc. received a substantially equivalent (SESE) decision for the Arthrex Beaming System under 510(k) number K262975, dated September 25, 2026, with the application received August 26, 2026. The device is classified as a bone fixation screw (21 CFR 888.3040) under product code HWC, with an orthopedic review panel. SESE denotes 510(k) clearance to market, not premarket approval.

The FDA letter describes the system as a fixation device system made of stainless steel, with beams ranging from 5 mm to 8 mm. The available excerpts do not identify a predicate device, the specific clinical indication, or the contents of any performance testing, so the basis for the equivalence determination remains unknown from this material. The record also does not state whether the submission covered a new device or a modification of a previously cleared system.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 25, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262975
Regulatory pathway
510(k) premarket notification
Applicant
ARTHREX, INC.
Product code
HWC
Decision code
SESE
Decision date
Sep 25, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Screw, Fixation, Bone.

Applicant
Arthrex, Inc.
Product code
HWC
FDA device class
2

FDA decision timeline

  1. K262975 received

    Application receipt date recorded by FDA.

  2. K262975 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HWC

Product / regulatory recordCompanyPathwayDecision dateSource
GM Dos Reis Industria e Comercio Ltda.510(k) clearanceNov 2, 2026FDA
Nvision Biomedical Technologies510(k) clearanceOct 14, 2026FDA
OsteoCentric Technologies510(k) clearanceOct 2, 2026FDA
MEDSHAPE, INC.510(k) clearanceSep 23, 2026FDA
Steps Ortho510(k) clearanceSep 21, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Arthrex, Inc.

Headquarters
Not reported
Brand website
arthrex.com
FDA applicant address
Naples, FL

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records